FeesSafety
Pluang+

Easterly Government Properties raises 2026 Core FFO guidance with 8% dividend yield on strong federal leases

Market News
10 Nov 2026, 14:35 WIB
Seeking Alpha
View Source
Bullish
Easterly Government Properties raises 2026 Core FFO guidance with 8% dividend yield on strong federal leases

Easterly Government Properties, specializing in real estate leased to the federal government, reported an 8% increase in third-quarter cash available for distribution. The company raised its full-year 2026 Core FFO guidance, supported by leases backed by the U.S. government that offer strong credit protection and renewal rates near 90%. With an 8% dividend yield, it provides a defensive income stream for investors amid high interest rates. This makes it an attractive option for those seeking stable, high-yield investments while waiting for interest rates to ease.

Easterly Government Properties is the subject, with Pluang's Real Estate sector data providing market context. As of Nov 10, 2026 19:13 WIB, among 47 priced US Real Estate stocks tradable on Pluang, 20 rose and 17 fell. Notable movers include Macerich Company at USD 25.21 with a -0.32% change and a typical hold time of 26 days, Iron Mountain Inc at USD 111.17 up 0.29% with an 81-day hold, and Innovative Industrial Properties Inc at USD 55.69 up 0.27%, with a 51% sell to 49% buy order activity and an 89-day typical hold time.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
56 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
56 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
56 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
56 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App